apotheek l. goegebeur
ActiveSummary
apotheek l. goegebeur has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €469k and a net result of €236k. Equity is growing by ~13.9% per year across the filed fiscal years. Its solvency ranks better than 54% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability94▲+4
Solvency65▲+8
Growth78=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 1.92 against 1.64 in 2024; short-term debt: 33% and cash: 15.7% of total assets), but 59.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
40.4%
Return on assets
20.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-07-2026, 20 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
20 d early
2024
36 d early
2023
on the day
2022
32 d early
2021
31 d early
2020
30 d late
2019
94 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€469k▲ 27.2%
2024 · €369k
2018: €198k
2019: €193k
2020: €193k
2021: €251k
2022: €288k
2023: €309k
2024: €369k
2018 → 2025
Total assets
€1.16M▼ 0.2%
2024 · €1.16M
2018: €850k
2019: €1.36M
2020: €1.18M
2021: €1.10M
2022: €1.05M
2023: €1.11M
2024: €1.16M
2018 → 2025
Net result
€236k▲ 18.3%
2024 · €199k
2018: €25k
2019: €-5k
2020: €-69
2021: €58k
2022: €37k
2023: €121k
2024: €199k
2018 → 2025
Working capital
€352k▲ 27.1%
2024 · €277k
2018: €256k
2019: €315k
2020: €266k
2021: €302k
2022: €302k
2023: €257k
2024: €277k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€251k-€288k▲ 14.9%€309k▲ 7.3%€369k▲ 19.2%€469k▲ 27.2%
Operating result€72k-€57k▼ 21.0%€141k▲ 148%€232k▲ 64.4%€281k▲ 21.0%
Net result€58k-€37k▼ 35.8%€121k▲ 225%€199k▲ 64.5%€236k▲ 18.3%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 21% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.16M
Fixed assets
€425k ▼ 6.6%
Current assets
€735k ▲ 3.9%
Equity and liabilities €1.16M
Equity
€469k ▲ 27.2%
Debt
€691k ▼ 13.0%
Debt's share of the balance-sheet total falls from 68.3% to 59.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€338k▲
2024 · €308k
Cash flow
€293k▲
2024 · €275k
Current ratio
1.92▲
2024 · 1.64
Quick ratio
0.88▲
2024 · 0.85
Debt to equity
1.47▼
2024 · 2.15
ROE
50.3%▼
2024 · 54.1%
ROA
20.3%▲
2024 · 17.1%
Interest coverage
22.70▲
2024 · 18.01
Debt ≤ 1 year
€383k▼
2024 · €430k
Debt > 1 year
€307k▼
2024 · €363k
Income taxes
€35k▲
2024 · €21k
Staff costs
€123k▲
2024 · €112k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 55 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.16M€1.16M▼
Fixed assets21/28€455k€425k▼
Intangible fixed assets21€24-
Tangible fixed assets22/27€450k€420k▼
Plant, machinery and equipment23€387k€365k▼
Furniture and vehicles24€33k€29k▼
Other tangible fixed assets26€30k€25k▼
Financial fixed assets28€5k€5k=
Current assets29/58€707k€735k▲
Stocks and contracts in progress3€342k€397k▲
Stocks30/36€342k€397k▲
Amounts receivable within one year40/41€194k€136k▼
Trade receivables40€150k€133k▼
Other amounts receivable41€44k€4k▼
Cash at bank and in hand54/58€154k€182k▲
Deferred charges and accrued income490/1€17k€20k▲
Equity and liabilities
Total equity and liabilities10/49€1.16M€1.16M▼
Equity10/15€369k€469k▲
Contributions10/11€153k€153k=
Reserves13€216k€316k▲
Tax-exempt reserves132€188€188=
Distributable reserves133€215k€316k▲
Amounts payable17/49€794k€691k▼
Amounts payable after more than one year17€363k€307k▼
Financial debts170/4€363k€307k▼
Amounts payable within one year42/48€430k€383k▼
Current portion of amounts payable after more than one year42€87k€56k▼
Financial debts43€2€41▲
Credit institutions430/8€2€41▲
Trade debts44€115k€129k▲
Suppliers440/4€115k€129k▲
Taxes, remuneration and social security45€27k€23k▼
Taxes450/3€17k€8k▼
Remuneration and social security454/9€10k€16k▲
Other amounts payable47/48€201k€175k▼
Accrued charges and deferred income492/3-€230
Income statement
Code20242025
Remuneration, social security and pensions62€112k€123k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€76k€57k▼
Other operating charges640/8€9k€5k▼
Gross operating margin9900€429k€467k▲
Operating profit (loss)9901€232k€281k▲
Financial income75/76B€5k€5k▼
Recurring financial income75€5k€5k▼
Financial charges65/66B€17k€15k▼
Recurring financial charges65€17k€15k▼
Profit (loss) for the period before taxes9903€220k€271k▲
Income taxes67/77€21k€35k▲
Profit (loss) for the period9904€199k€236k▲
Profit (loss) for the period to be appropriated9905€199k€236k▲
Appropriation of the result
Profit (loss) to be appropriated9906€199k€236k▲
Transfer to equity691/2€59k€100k▲
To other reserves6921€59k€100k▲
Profit to be distributed694/7€140k€135k▼
Directors or managers695€140k€135k▼
Social balance
Average headcount (FTE)90872.42.6▲
The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €236k ▲18.3%
Operating result €281k, net result €236k, both a record.
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Back to profitnet €58k
Net result €58k after 2 loss-making years.
31-12
Financial
Equity above €200kEq €251k ▲30.2%
Equity rises from €193k to €251k.
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
02-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 94 days late
2019
31-12
Financial
Weakest financial yearnet €-5k ▼119%
Net result drops to €-5k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
22-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
26-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 57 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Torhout · 2 establishment units since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oostendestraat 1548820 TorhoutGround area
1,665 m²
Building footprint
530 m²
Volume, LiDAR
2,924 m³
2 parcels, Flanders · tallest building 13.2 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Apotheek L. Goegebeur
since 20182.282.155.028
Apotheek L. Goegebeur
since 20192.308.149.840
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31033I0638/00C000 | Flanders | 930 m² | 1 · 412 m² | 10.1 m · 1 fl. |
| 31523F0695/00X000 | Flanders | 735 m² | 1 · 118 m² | 13.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 · 1 entry · 4,000 EUR awarded · 4,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 4,000 EUR | 4,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Food safety, FASFC
2 sitesTorhout2.282.155.028
Torhout2.308.149.840
Similar companies · same sector, comparable size
PHARMACIE DU VERT CHASSEUR
BE 0817.678.029
Ukkel · Eq €468,779
LES PHARMACIES LAMBRECHTS
BE 0448.543.638
Sint-Jans-Molenbeek · Eq €469,117
Apotheek Grillet
BE 0408.161.746
Moorslede · Eq €469,257
PHARMACIE SMEETS LAMPROYE
BE 0878.608.974
Gesves · Eq €467,916
DRIEKONINGEN
BE 0438.821.169
Sint-Niklaas · Eq €467,689
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,383 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-02-2004
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.